## Background: It has been suggested that cyclin-dependent kinase inhibitors (cdkis), including p16 and p15, are tumor suppressor genes. alterations of cdkis have been found in most types of cancer. however, little is known about the status of p16 and p15 genes, including methylation of the promote
Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts
✍ Scribed by Noble, Jane R; Zhong, Ze-Huai; Neumann, Axel A; Melki, John R; Clark, Susan J; Reddel, Roger R
- Book ID
- 110068517
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 256 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The p16 INK4A gene, which encodes the cell-cycle regulatory protein cyclin-dependent kinase 4 inhibitor, is a putative tumor-suppressor gene. We examined p16 gene alterations in 30 primary ovarian cancers and 11 ovarian cancer cell lines. Five of the primary cancers (16.7%) had lost both p16 INK4A g
## Abstract B‐cell chronic lymphocytic leukemia (B‐CLL) samples were screened for alterations in multiple tumor suppressor genes (__p53__ (17p13), __p__16 INK^4^ (9p21), and disrupted in B‐cell malignancy (__DBM__) (13q14)) by using poly‐merase chain reaction‐based assays. Eleven percent (11 of 96)
## Abstract Aberrant promoter methylation is an important mechanism for gene silencing. In the present study, 50 Barrett's esophagus‐associated esophageal adenocarcinomas (ADC), 50 cardiac ADC and 50 gastric ADC were investigated by means of methylation‐specific real‐time PCR for hypermethylation i